| [1] |
López-Díez R, Shekhtman A, Ramasamy R, et al. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity[J]. Biochim Biophys Acta, 2016, 1862(12): 2244-2252.
|
| [2] |
Cui CL, Loanzon RS, Southerland KW, et al. A national analysis of vascular surgery resident operative experience in peripheral artery disease[J]. J Vasc Surg, 2023, 78(6): 1541-1547.
|
| [3] |
王深明, 王劲松. 下肢动脉粥样硬化闭塞症治疗的现状与展望[J]. 中国实用外科杂志, 1998, 18(9): 46-49.
|
| [4] |
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia[J]. Eur J Vasc Endovasc Surg, 2019, 69(6s): 3S-125S.
|
| [5] |
Morisaki K, Matsuda D, Guntani A, et al. Treatment outcomes between bypass surgery and endovascular therapy in patients with chronic limb-threatening ischemia classified as bypass-preferred category based on Global Vascular Guidelines[J]. J Vasc Surg, 2023, 78(2): 475-482, e1.
|
| [6] |
Jongkind V, Akkersdijk GJ, Yeung KK, et al. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease[J]. J Vasc Surg, 2010, 52(5): 1376-1383.
|
| [7] |
Premaratne S, Newman J, Hobbs S, et al. Meta-analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease[J]. J Vasc Surg, 2020, 72(2): 726-737.
|
| [8] |
Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy[J]. J Vasc Surg, 2010, 51(5 Suppl): 5s-17s.
|
| [9] |
Farber A, Menard MT, Conte MS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia[J]. N Engl J Med, 2022, 387(25): 2305-2316.
|
| [10] |
Takahashi EA, Lookstein RA, Misra S. Best endovascular versus best surgical therapy in patients with CLI (BEST-CLI) trial: A misleading trial name[J]. J Vasc Interv Radiol, 2023, 34(4): 718-719.
|
| [11] |
Kodama A, Meecham L, Popplewell M, et al. Editor’s choice - relationship between Global Limb Anatomic Staging System (GLASS) and clinical outcomes following revascularisation for chronic limb threatening ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial[J]. Eur J Vasc Endovasc Surg, 2020, 60(5): 687-695.
|
| [12] |
罗新, 黄可, 黄斌, 等. 下肢慢性肢体威胁性缺血合并糖尿病的单中心治疗体会[J]. 四川大学学报(医学版), 2022, 53(6): 988-992.
|
| [13] |
Nakama T, Takahara M, Iwata Y, et al. 1-year outcomes of thromboendarterectomy vs endovascular therapy for common femoral artery lesions: CAULIFLOWER study results[J]. JACC Cardiovasc Interv, 2022, 15(14): 1453-1463.
|
| [14] |
Popplewell MA, Davies HOB, Narayanswami J, et al. A comparison of outcomes in patients with infrapopliteal disease randomised to vein bypass or plain balloon angioplasty in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL) trial[J]. Eur J Vasc Endovasc Surg, 2017, 54(2): 195-201.
|
| [15] |
Bradbury AW, Moakes CA, Popplewell M, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): An open-label, randomised, multicentre, phase 3 trial[J]. Lancet, 2023, 401(10390): 1798-1809.
|
| [16] |
Dayama A, Tsilimparis N, Kolakowski S, et al. Clinical outcomes of bypass-first versus endovascular-first strategy in patients with chronic limb-threatening ischemia due to infrageniculate arterial disease[J]. J Vasc Surg, 2019, 69(1): 156-163, e1.
|
| [17] |
Santo VJ, Dargon P, Azarbal AF, et al. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure[J]. J Vasc Surg, 2014, 60(1): 129-135.
|
| [18] |
Betz T, Ingolf T, Markus S, et al. Evaluation of long-term outcomes of femoropopliteal bypass surgery in patients with chronic limb-threatening ischemia in an endovascular era[J]. Ann Vasc Surg, 2022, 79: 191-200.
|
| [19] |
Nierlich P, Enzmann FK, Metzger P, et al. Arm vein versus small saphenous vein for lower extremity bypass in the absence of both great saphenous veins[J]. Ann Vasc Surg, 2021, 70: 341-348.
|
| [20] |
Giusti JCG, Rossi FH, Cury MVM, et al. Efficacy and safety of iliofemoral bypass using arm veins as an alternative conduit for chronic limb-threatening ischemia[J]. J Vasc Surg, 2023, 78(4): 1021-1029, e3.
|
| [21] |
Biroš E, Staffa R, Krejčí M, et al. Autologous alternative vein grafts for infrainguinal bypass in the absence of single-segment great saphenous vein: A single-center study[J]. Ann Vasc Surg, 2024, 103: 133-140.
|
| [22] |
Dorigo W, Fargion A, Bassoli G, et al. Autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene as graft materials for below-the-knee femoro-popliteal bypass in patients with critical limb ischemia: A propensity score-matched analysis[J]. Surgeon, 2022, 20(2): 85-93.
|
| [23] |
O’Banion LA, Wu B, Eichler CM, et al. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage[J]. J Vasc Surg, 2017, 66(3): 844-849.
|
| [24] |
Furlough CL, Jain AK, Ho KJ, et al. Peripheral artery reconstructions using cryopreserved arterial allografts in infected fields[J]. J Vasc Surg, 2019, 70(2): 562-568.
|
| [25] |
Thomas JP, So KL, Turner JT, et al. Optimal conduit choice for open lower extremity bypass in chronic limb-threatening ischemia[J]. Semin Vasc Surg, 2022, 35(2): 172-179.
|
| [26] |
Gutowski P, Gage SM, Guziewicz M, et al. Arterial reconstruction with human bioengineered acellular blood vessels in patients with peripheral arterial disease[J]. J Vasc Surg, 2020, 72(4): 1247-1258.
|
| [27] |
Shan LL, Yang LS, Tew M, et al. Quality of life in chronic limb threatening ischaemia: systematic review and Meta-analysis[J]. Eur J Vasc Endovasc Surg, 2022, 64(6): 666-683.
|